Advertisement

Two Memorial Sloan Kettering Experts Awarded for Pioneering Work


Advertisement
Get Permission

Memorial Sloan Kettering Cancer Center (MSK) recently announced that Larry Norton, MD, Senior Vice President, Office of the President; and Medical Director of the Evelyn H. Lauder Breast Center, has been elected to the American Academy of the Arts & Sciences, an honorary society that recognizes excellence in every field, discipline, and profession. In addition, ­Michel Sadelain, MD, PhD, Director of MSK’s Center for Cell Engineering, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT).

Larry Norton, MD

Larry Norton, MD

Michel Sadelain, MD, Ph

Michel Sadelain, MD, Ph

Elected to Academy of Arts & Sciences

The American Academy of Arts & Sciences announced Dr. Norton’s election to the Academy among the 252 individuals confirmed as part of the 2021 class. He joins a select group of the nation’s most prominent scholars, scientists, writers, and artists as well as civic, business, and philanthropic leaders who already include 21 past and present MSK faculty members and one Board member.

Dr. Norton is a leader in breast cancer treatment and research, recognized for his expertise in the biology and mathematical principles underlying the formation and development of tumors. His research is aimed at developing more effective approaches for cancer diagnosis, treatment, and prevention.

Election to the Academy of Arts & Sciences is one of the most significant honors anyone can earn. Founded in 1780 by John Adams, John ­Hancock, and 60 other scholar-patriots, the Academy was created with the recognition that a new nation would require institutions and individuals committed to advancing knowledge in service to the public good.

Honored by ASGCT

Dr. Sadelain has been named the recipient of the Outstanding Achievement Award from the ASGCT for his seminal research on chimeric antigen receptors. The Outstanding Achievement Award recognizes an ASGCT member who has achieved a pioneering research success, specific high-impact accomplishment, or lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor. Dr. ­Sadelain was recognized at this year’s Annual Meeting, held virtually May 11–14, where he presented a plenary lecture highlighting his scientific accomplishments that led to this honor. 

 


Advertisement

Advertisement



Advertisement